Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): Lessons from genetically modified mice

Journal of Physiology

Volumn 546, Issue 1, 2003, Pages 63-75

  Massion, P B ^a   Balligand, J L ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CARBACHOL; CATECHOLAMINE; CORTICOSTEROID DERIVATIVE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOENZYME; ISOPRENALINE; LYASE INHIBITOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OUABAIN; PROSTACYCLIN; RECEPTOR SUBTYPE; CAVEOLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 90;

CHOLINERGIC STIMULATION; DIASTOLE; DRUG MECHANISM; ENDOTHELIUM; GENE DELETION; GENE OVEREXPRESSION; GENETIC LINKAGE; HEART CONTRACTION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; HEART MUSCLE REPERFUSION; HEART RATE; HEART STIMULATION; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INOTROPISM; MORTALITY; MOUSE; MOUSE STRAIN; NEUROMODULATION; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SYSTOLE; TRANSGENIC MOUSE; UPREGULATION; GENETICALLY ENGINEERED MOUSE STRAIN; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART STRESS; MODULATION; MOLECULAR MODEL; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 0037232585     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.025973     Document Type: Review

References (83)

1. Ashley EA, Sears CE, Bryant SM, Watkins HC & Casadei B (2002). Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes. Circulation 105, 3011-3016.
2. Balligand JL (1999). Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovasc Res 43, 607-620.
3. Balligand JL (2002). Heat shock protein 90 in endothelial nitric oxide synthase signaling: following the lead(er)? Circ Res 90, 838-841.
4. Balligand JL, Kelly RA, Marsden PA, Smith TW & Michel T (1993). Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A 90, 347-351.
5. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW & Michel T (1995). Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 270, 14582-14586.
6. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE & Hare JM (2002). Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416, 337-339.
7. Bartunek J, Shah AM, Vanderheyden M & Paulus WJ (1997). Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation. Circulation 95, 90-96.
8. Bates TE, Loesch A, Burnstock G & Clark JB (1996). Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun 218, 40-44.
9. Beckman JS, Beckman TW, Chen J, Marshall PA & Freeman BA (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87, 1620-1624.
10. 2+ current is not altered in cardiac ventricular myocytes from mice lacking endothelial nitric oxide synthase. J Physiol 528, 279-289.
11. Bell RM & Yellon DM (2001). The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice. Cardiovasc Res 52, 274-280.
12. Bett GC, Dai S & Campbell DL (2002). Cholinergic modulation of the basal L-type calcium current in ferret right ventricular myocytes. J Physiol 542, 107-117.
13. Blumenthal DK, Stull JT & Gill GN (1978). Phosphorylation of cardiac troponin by guanosine 3′:5′-monophosphate-dependent protein kinase. J Biol Chem 253, 324-326.
14. Boknik P, Heinroth-Hoffmann I, Kirchhefer U, Knapp J, Linck B, Luss H, Muller T, Schmitz W, Brodde O & Neumann J (2001). Enhanced protein phosphorylation in hypertensive hypertrophy. Cardiovasc Res 51, 717-728.
15. Bolli R (2001). Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33, 1897-1918.
16. Brunner F, Andrew P, Wolkart G, Zechner R & Mayer B (2001). Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104, 3097-3102.
17. Campbell DL, Stamler JS & Strauss HC (1996). Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 108, 277-293.
18. Choate JK, Danson EJ, Morris JF & Paterson DJ (2001). Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice. Am J Physiol 281, H2310-2317.
19. Cotton JM, Kearney MT, MacCarthy PA, Grocott-Mason RM, McClean DR, Heymes C, Richardson PJ & Shah AM (2001). Effects of nitric oxide synthase inhibition on basal function and the force-frequency relationship in the normal and failing human heart in vivo. Circulation 104, 2318-2323.
20. Crane BR, Arvai AS, Ghosh DK, Wu C, Getzoff ED, Stuehr DJ & Tainer JA (1998). Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279, 2121-2126.
21. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H & Kurzchalia TV (2001). Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452.
22. Elfering SL, Sarkela TM, Giulivi C(2002). Biochemistry of mitochondrial nitric-oxide synthase. J Biol Chem 277, 38079-38086.
23. Elvan A, Rubart M & Zipes DP (1997). NO modulates autonomic effects on sinus discharge rate and AV nodal conduction in open-chest dogs. Am J Physiol 272, H263-271.
24. 2 sensor and NO signaling functions. Cell 102, 499-509.
25. Feron O, Dessy C, Desager JP & Balligand JL (2001). Hydroxymethylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103, 113-118.
26. Feron O, Dessy C, Opel DJ, Arstall MA, Kelly RA & Michel T (1998b). Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem 273, 30249-30254.
27. Feron O, Michel JB, Sase K & Michel T (1998a). Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistry 37, 193-200.
28. 2+/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88, E68-75.
29. Flogel U, Decking UK, Godecke A & Schrader J (1999). Contribution of NO to ischemia-reperfusion injury in the saline- perfused heart: a study in endothelial NO synthase knockout mice. JMol Cell Cardiol 31, 827-836.
30. Forstermann U, Boissel JP & Kleinert H (1998). Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12, 773-790.
31. French S, Giulivi C & Balaban RS (2001). Nitric oxide synthase in porcine heart mitochondria: evidence for low physiological activity. Am J Physiol 280, H2863-2867.
32. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A & Sessa WC (1998). Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392, 821-824.
33. Gauthier C, Leblais, Kobzik, L, Trochu JN, Khandoudi N, Bril A, Balligand JL & Le Marec H (1998). The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102, 1377-1384.
34. Godecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon HJ, Godecke S & Schrader J (1998). Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 82, 186-194.
35. Godecke A, Heinicke T, Kamkin A, Kiseleva I, Strasser RH, Decking UK, Stumpe T, Isenberg G & Schrader J (2001). Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J Physiol 532, 195-204.
36. +-channel expression of cultured neonatal rat ventricular myocytes. Am J Physiol 272, H2599-2606.
37. Guo Y, Jones, WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y & Bolli R (1999). The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A 96, 11507-11512.
38. Gyurko R, Kuhlencordt P, Fishman MC & Huang PL (2000). Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol 278, H971-981.
39. Hafezi-Moghada, A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh C, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K & Liao JK (2002). Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8, 473-479.
40. 2+ current in adult rabbit atrioventricular nodal cells. Circ Res 78, 998-1008.
41. Ca-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 95, 6510-6515.
42. Han X, Shimoni Y & Giles WR (1995). A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate. J Gen Physiol 106, 45-65.
43. Hannan RL, John MC, Kouretas PC, Hack BD, Matherne GP & Laubach VE (2000). Deletion of endothelial nitric oxide synthase exacerbates myocardial stunning in an isolated mouse heart model. J Surg Res 93, 127-132.
44. Hare JM, Keaney JF Jr, Balligand JL, Loscalzo J, Smith TW & Colucci WS (1995). Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. Journal of Clinical Investigation 95, 360-366.
45. Hart CY, Hahn EL, Meyer DM, Burnett JC Jr & Redfield MM (2001). Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs. Am J Physiol 281, H146-154.
46. f, and heart rate during adrenergic stimulation. Cardiovasc Res 52, 446-453.
47. Janssens, S. P., Simouchi, A., Quertermous, T., Bloch, D. B. & Bloch, K. D. (1992). Cloning and expression of a cDNA encoding human endothelium-derived relating factor/nitric oxide synthase. Journal of Biological Chemistry 267, 14519-14522; published erratum Journal of Biological Chemistry 267, 22694.
48. 2+ channel during cardiomyogenesis: switch from NO to adenylyl cyclase-mediated inhibition. FASEB J 13, 313-324.
49. Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, Jourd'Heuil, D, Huang PL & Lefer DJ (1999). Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol 276, H1567-1573.
50. Jumrussirikul P, Dinerman J, Dawson TM, Dawson VL, Ekelund U, Georgakopoulos D, Schramm LP, Calkins H, Snyder SH, Hare JM & Berger RD (1998). Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J Clin Invest 102, 1279-1285.
51. Kanai AJ, Mesaros S, Finkel MS, Oddis CV, Birder LA & Malinski T (1997). β-Adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes. Am J Physiol 273, C1371-1377.
52. Kanai AJ, Pearce LL, Clemens PR, Birder LA, Vanbibber MM, Choi SY, De Groat WC & Peterson J (2001). Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci U S A 98, 14126-14131.
53. Kanno S, Lee PC, Zhang Y, Ho C, Griffith BP, Shears LL & Billiar TR (2000). Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation 101, 2742-2748.
54. 2+-independent manner in cardiac myocytes: role of troponin I phosphorylation. Biochem Biophys Res Commun 256, 398-403.
55. Kojda G, Kottenberg K, Nix P, Schluter KD, Piper HM & Noack E (1996). Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78, 91-101.
56. Kojda G, Kottenberg K & Noack E (1997). Inhibition of nitric oxide syntbase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts. Eur J Pharmacol 334, 181-190.
57. Kojda G, Laursen JB, Ramasamy S, Kent JD, Kurz S, Burchfield J, Shesely EG & Harrison DG (1999). Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control. Cardiovasc Res 42, 206-213.
58. Kubis N, Besnard S, Silvestre JS, Feletou M, Huang PL, Levy BI & Tedgui A (2002). Decreased arteriolar density in endothelial nitric oxide synthase knockout mice is due to hypertension, not to the constitutive defect in endothelial nitric oxide synthase enzyme. J Hypertens 20, 273-280.
59. Kubota I, Han X, Opel DJ, Zhao YY, Baliga R, Huang P, Fishman MC, Shannon RP, Michel T & Kelly RA (2000). Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase. J Mol Cell Cardiol 32, 1239-1248.
60. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, Picard MH & Huang PL (2001). Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104, 448-454.
61. Lamas S, Marsden PA, Li GK, Tempst P & Michel T (1992). Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A 89, 6348-6352.
62. Layland J, Li JM & Shah AM (2002). Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol 540, 457-467.
63. Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R & Bolli R (2001). Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 103, 2935-2941.
64. Levin KR & Page E (1980). Quantitative studies on plasmalemmal folds and caveolae of rabbit ventricular myocardial cells. Circ Res 46, 244-255.
65. Levy MN (1971). Sympathetic-parasympathetic interactions in the heart. Circulation Research 29, 437-445.
66. Lincoln TM & Corbin JD (1978). Purified cyclic GMP-dependent protein kinase catalyzes the phosphorylation of cardiac troponin inhibitory subunit (TN-1). J Biol Chem 253, 337-339.
67. Liu YH, Xu J, Yang JP, Yang F, Shesely E & Carretero OA (2002). Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure. Hypertension 39, 375-381.
68. Marletta MA (1993). Nitric oxide synthase structure and mechanism. Journal of Biological Chemistry 268, 12231-12234.
69. Massion P, Moniotte S & Balligand J (2001). Nitric oxide: does it play a role in the heart of the critically ill? Current Opinion in Critical Care 7, 323-336.
70. Matter CM, Mandinov L, Kaufmann PA, Vassalli G, Jiang Z & Hess OM (1999). Effect of NO donors on LV diastolic function in patients with severe pressure-overload hypertrophy. Circulation 99, 2396-2401.
71. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci U S A 88, 1197-1201.
72. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268, 26286-26295.
73. Michel JB, Feron O, Sase K, Prabhakar P & Michel T (1997). Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 272, 25907-25912.
74. Mohan P, Brutsaert DL, Paulus WJ & Sys SU (1996). Myocardial contractile response to nitric oxide and cGMP. Circulation 93, 1223-1229.
75. 3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103, 1649-1655.
76. Muller-Strahl G, Kottenberg K, Zimmer HG, Noack E & Kojda G (2000). Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart. J Physiol 522, 311-320.
77. Xuan YT, Tang XL, Qiu Y, Banerjee S, Takano H, Han H & Bolli R (2000). Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol 279, H2360-2371.
78. Yang XP, Liu YH, Shesely EG, Bulagannawar M, Liu F & Carretero OA (1999). Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury. Hypertension 34, 24-30.
79. Yasmin W, Strynadka KD & Schulz R (1997). Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 33, 422-432.
80. f) in sino-atrial node cells of the rabbit. J Mol Cell Cardiol 30, 2729-2738.
81. Zahradnikova A, Minarovic I, Venema RC & Meszaros LG (1997). Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium 22, 447-454.
82. 2+ sparks: Influence of β-adrenergic stimulation. Am J Physiol 281, H2295-2303.
83. Zou MH, Shi C & Cohen RA (2002). Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Investig 109, 817-826.